NSC |
Compound |
Enrichment |
Correlation |
NSC 707465 |
2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- |
0.0278435641331422 |
0.083081287 |
NSC 709100 |
Null |
0.0278435641331422 |
0.20993549 |
NSC 722985 |
Null |
0.0278435641331422 |
0.13073401 |
NSC 728040 |
2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline |
0.0278435641331422 |
0.17496773 |
NSC 743432 |
2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione |
0.0278435641331424 |
0.19669077 |
NSC 745813 |
Null |
0.0278435641331424 |
0.079272895 |
NSC 757981 |
Null |
0.0278435641331424 |
0.049335751 |
NSC 746149 |
N,N'-bis(4-bromo-2-fluorobenzoyl)-L-selenocystine bis(4-methoxyphenacyl) ester hemihydrate |
0.0303322639291196 |
-0.28977419 |
NSC 749147 |
Null |
0.0303322639291196 |
0.23330703 |
NSC 81052 |
Streptonigrin analog (MeO-N3) |
0.0303322639291196 |
0.18622278 |